Lipid infiltration in the parotid glands: A clinical manifestation of metabolic syndrome

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 2, 2012, Pages 110-115

  Hida, A ^a   Akahoshi, M ^a   Takagi, Y ^b   Imaizumi, M ^a   Sera, N ^a   Soda, M ^a   Maeda, R ^a   Nakashima, E ^a   Ida, H ^c   Kawakami, A ^c   Nakamura, T ^b   Eguchi, K ^c  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

coronary risk factors; fatty liver; sicca syndrome

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ANTHROPOMETRY; ARTICLE; ATOMIC BOMB SURVIVOR; BODY MASS; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ECHOGRAPHY; ENDOCRINE FUNCTION TEST; FATTY LIVER; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAPAN; LACRIMATION; LIPID INFILTRATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE; SALIVATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ALGORITHMS; COHORT STUDIES; FEMALE; HUMANS; JAPAN; LIPID METABOLISM DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; NUCLEAR WEAPONS; PAROTID DISEASES; QUESTIONNAIRES; RADIOACTIVE HAZARD RELEASE; RISK FACTORS; SJOGREN'S SYNDROME; SURVIVORS;

EID: 84857039509     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1291315     Document Type: Article

References (32)

1. Akahoshi M, Amasaki Y, Soda M et al. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. Hypertens Res: 2001; 24 337 343 (Pubitemid 32791809)
2. Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med: 1998; 15 539 553 (Pubitemid 28319935)
3. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun: 1999; 257 79 83 (Pubitemid 29299050)
4. Atomic Bomb Casualty Commission Research plan for joint ABCC-NIH Adult Health Study in Hiroshima and Nagasaki, Japan. ABCC Technical Report.: 1962; 11 62
5. Baba T, Amasaki Y, Soda M et al. Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertens Res: 2007; 30 823 829 (Pubitemid 47578244)
6. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome Definition and the diagnostic standard for metabolic syndrome - Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nippon Naika Gakkai Zasshi: 2005; 94 794 809
7. Goldman J A, Julian E H. Pseudo-Sjogren syndrome with hyperlipoproteinemia. JAMA: 1977; 237 1582 1584
8. Hayashi T, Boyko E J, Leonetti D L et al. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation: 2003; 108 1718 1723 (Pubitemid 37243660)
9. Hida A, Akahoshi M, Takagi Y et al. Prevalence of Sjogren syndrome among Nagasaki atomic bomb survivors. Ann Rheum Dis: 2008; 67 689 695 (Pubitemid 351571935)
10. International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care: 2009; 32 1327 1334
11. Iwashima Y, Katsuya T, Ishikawa K et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension: 2004; 43 1318 1323 (Pubitemid 38691756)
12. Izumi M, Hida A, Takagi Y et al. MR imaging of the salivary glands in sicca syndrome: comparison of lipid profiles and imaging in patients with hyperlipidemia and patients with Sjogrens syndrome. Am J Roentgenol: 2000; 175 829 834
13. Kaltreider H B, Talal N. Bilateral parotid gland enlargement and hyperlipoproteinemia. JAMA: 1969; 210 2067 2070
14. Kohler P F, Winter M E. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum: 1985; 28 1128 1132 (Pubitemid 16250648)
15. Kumada M, Kihara S, Sumitsuji S et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol: 2003; 23 85 89 (Pubitemid 36091630)
16. Lamey P J, Darwazeh A M, Frier B M. Oral disorders associated with diabetes mellitus. Diabet Med: 1992; 9 410 416
17. Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes: 2001; 50 1844 1850 (Pubitemid 33641605)
18. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation: 2002; 106 3143 3421
19. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation: 1999; 100 2473 2476 (Pubitemid 30005109)
20. Pierce D A, Stram D O, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res: 1990; 123 275 284 (Pubitemid 20327898)
21. Rasouli N, Molavi B, Elbein S C et al. Ectopic fat accumulation and metabolic syndrome. Diabetes Obes Metab: 2007; 9 1 10 (Pubitemid 44921036)
22. Russotto S B. Asymptomatic parotid gland enlargement in diabetes mellitus. Oral Surg Oral Med Oral Pathol: 1981; 52 594 598 (Pubitemid 12182758)
23. Ruttmann E, Brant L J, Concin H et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation: 2005; 112 2130 2137 (Pubitemid 41475806)
24. Seino Y, Nanjo K, Tajima N et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int; 2010; 1 2 20
25. Sheikh J S, Sharma M, Kunath A et al. Reversible parotid enlargement and pseudo-Sjogrens syndrome secondary to hypertriglyceridemia. J Rheumatol: 1996; 23 1288 1291
26. Sreebny L M, Yu A, Green A et al. Xerostomia in diabetes mellitus. Diabetes Care: 1992; 15 900 904
27. Takagi Y, Sumi M, Sumi T et al. MR microscopy of the parotid glands in patients with Sjogrens syndrome: quantitative MR diagnostic criteria. Am J Neuroradiol: 2005; 26 1207 1214 (Pubitemid 43821974)
28. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogrens syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis: 2002; 61 554 558 (Pubitemid 34539104)
29. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab: 2001; 86 1930 1935 (Pubitemid 32472900)
30. Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med: 2002; 8 1288 1295 (Pubitemid 35373562)
31. Yang W S, Lee W J, Funahashi T et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab: 2001; 86 3815 3819 (Pubitemid 32755982)
32. Young R, Kerr G. Reassessment of the Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki - Dosimetry System 2002. Hiroshima Radiation Effects Research Foundation: 2005